Chronic renal disease and risk of cardiovascular morbidity-mortality

Kidney and Blood Pressure Research

Volumn 39, Issue 2-3, 2014, Pages 142-146

  Santoro, Antonio ^a   Mandreoli, Marcora ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Ospedale S Maria della Scaletta   (Italy)

Author keywords

Cardiovascular disease; Chronic Kidney Disease; CKD; CV risk; Proteinuria

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY FUNCTION; MORBIDITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING CESSATION; VASCULAR DISEASE; CARDIOVASCULAR DISEASES; COMPLICATION; PATHOLOGY; RENAL INSUFFICIENCY, CHRONIC; RISK;

CARDIOVASCULAR DISEASES; HUMANS; RENAL INSUFFICIENCY, CHRONIC; RISK; RISK FACTORS;

EID: 84906021952     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000355789     Document Type: Review

References (18)

1. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004;164:659-663.
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiov ascular events, and hospitalization. N Engl J Med 2004;351:1296-1305.
3. Schillaci G, Reboldi G, Verdecchia P: High-normal serum creatinine concentration is a predictor of cardiovascular risk in essen tial hypertension. Arch Intern Med 2001;161:886-891.
4. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipri l: The HOPE Randomized Trial. Ann Intern Med 2001;134:629-636.
5. Matsushita K, Van Der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT for the CKD Prognos is Consortium: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073-2081.
6. Van Der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, de Jong P, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium: Lower estimated glomerular filtration rate and higher albuminuria are ass ociated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int 2011;79:1341-1352.
7. Hillege HL, Fidler V, Diercks GF, Van Gilst WH, de Zeeuw D, Van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE: Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mo rtality in general population. Circulation 2002;106:1777-1782.
8. Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W: Chronic kidney disease, anemia, and incident stroke in a middle-A ged, community-based population: the ARIC study. Kidney Int 2003;64:610-615.
9. Wattanakit K, Folsom AR, Selvin E, Coresh J, Hirsch AT, Weatherley BD: Kidney function and risk of periphera l arterial disease: results from the Atherosclerosis Risk In Communities (ARIC) study. J Am Soc Nephrol 2007;18:629-636.
10. Alonso A Lopez FL Matsushita K Loehr LR Agarwal SK Chen LY Soliman EZ Astor BC Coresh JChronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 2011 123 2946-2953.
11. Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ: Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J 2006;151:492-500.
12. Tonelli M, Muntner P, Lloyd A Manns BJ, Klarenbach S, Pannu N, James MT, Hemmelgarn BR, for the Alberta Kidney Disease Network: Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet 2012;380:807-814.
13. Kottgen A, Russell SD, Loehr LR, Crainiceanu CM, Rosamond WD, Chang PP, Chambless LE, Coresh J: Reduced kidney function as a risk factor for incident heart failure: the Atherosclerosis Risk In Communities (ARIC) study. J Am Soc Nephrol 2007;18:1307-1315.
14. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimber ger JD, Califf RM, Pfeffer MA: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351:1285-1295.
15. Dohi T, Miyauchi K, Okazaki S, Yokoyama T, Tamura H, Kojima T, Yokoyama K, Kurata T, Daida H: Long-term impact of mild chronic kidney disease in patients with acute coronary syndrome undergoing percutaneous coronary interventions. Nephrol Dial Transplan t 2011;26:2906-2911.
16. Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ, Lee BJ, Perkins RM, Rossing P, Sairenchi T, Tonelli M, Vassalotti JA, Yamagi shi K, Coresh J, de Jong PE, Wen CP, Nelson RG; Chronic Kidney Disease Prognosis Consortium: Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: A meta-analysis of 1 024 977 individuals. Lancet 2012;380:1662-1673.
17. Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, Rossing P, Sarnak MJ, Stengel B, Yamagishi K , Yamashita K, Zhang L, Coresh J, de Jong PE, Astor BC; Chronic Kidney Disease Prognosis Consortium: Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet 2012;380:1649-1661.
18. Schiffrin EL, Lipman ML, Mann JFE: Chronic Kidney Disease Effects on the Cardiovascular System. Circulation 2007;116:85-97.